ADVANCELL
AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
ADVANCELL
Industry:
Biotechnology Clinical Trials Oncology Pharmaceutical
Founded:
2019-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.advancell.com.au
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14.56 M USD
Technology used in webpage:
Google Maps CrUX Dataset CrUX Top 10m
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series B - AdvanCell
NSW Health
NSW Health investment in Grant - AdvanCell
Official Site Inspections
http://www.advancell.com.au Semrush global rank: 10.01 M Semrush visits lastest month: 282
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "AdvanCell"
Bringing Targeted Alpha - AdvanCell
About AdvanCell. AdvanCell is a radiopharmaceutical company that works with technology to develop a revolutionary cancer treatment called Targeted Alpha Therapy, providing new hope for patients with untreatable cancers. The major …See details»
AdvanCell - Crunchbase Company Profile & Funding
AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Sydney, New South Wales, Australia; 11-50; Series B; Private; advancell.com.au/ 33,502; …See details»
ADVANCELL PTY LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ADVANCELL PTY LIMITED of Sydney, NEW SOUTH WALES. Get the latest business insights from Dun & …See details»
First in-human images of new hope treatment for poor-prognosis …
Jun 24, 2024 However, AdvanCell’s technology has thrown open a door to more hope. They created a small generator that produces clinical doses of the isotope lead-212 daily, which …See details»
AdvanCell Company Profile 2024: Valuation, Funding & Investors
AdvanCell General Information Description. Operator of a radiopharmaceutical company intended for developing alpha therapies for cancer patients. The company develops alpha-emitting …See details»
Contact - AdvanCell
AdvanCell has deep experience in running clinical trials for radioligand therapies. AUSTRALIAN. Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and …See details»
AdvanCell Closes A$18M Series B Funding Led by Morningside
SYDNEY--(BUSINESS WIRE)-- AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, …See details»
AdvanCell Announces the Launch of its Flagship Facility to Support ...
Www.advancell.com.au Investors or Media: [email protected] AdvanCell Isotopes Pty Ltd ACN 633 959 010 Level 7 Macquarie House 167 Macquarie Street Sydney NSW 2000 …See details»
AdvanCell Announces First Patient Dosed in Phase I/II …
November 8, 2023 - SYDNEY, AUSTRALIA – AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a …See details»
Targeting a new generation of radiopharmaceuticals …
AdvanCell is an Australian-based clinical-stage radiopharmaceutical company that is developing a range of novel therapies to boost cancer survival rates and improve patients’ quality of life.. Delivering hyper-accurate cancer treatments. …See details»
AdvanCell Expands Leadership Team with the Appointment of …
SYDNEY, May 08, 2024--AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the …See details»
AusBiotech 2024 stand partners | State Development, …
Oct 25, 2024 AdvanCell. AdvanCell is an Australian clinical stage radiopharmaceutical company developing ²¹²Pb-based Targeted Alpha Therapies (TAT). AdvanCell’s proprietary alpha …See details»
A world-first alpha isotope generator - The Index Project
AdvanCell's Generator is a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable and scalable supply of isotope. The …See details»
News - AdvanCell
Andrew is a founder and Managing Director of AdvanCell Isotopes, and a founder and Director of Riverland Capital, a private investment firm. Read more. JULIAN KELLY. Chief Nuclear …See details»
Good Design Award of the Year — AdvanCell - Australian …
Sep 22, 2022 AdvanCell now routinely manufactures Alpha 212® (AdvanCell’s trademarked isotope product) through a fleet of the award-winning generators enabling full control of the …See details»
AdvanCell Alpha Isotope Generator | Radiopharmaceutical Device …
Medical Device Development: The next-generation AdvanCell Generator is a compact, innovative device that enables the commercial scale production of Lead-212 for targeted alpha therapies …See details»
Partners - AdvanCell
AdvanCell would like to acknowledge the National Isotope Development Center (NIDC) and the DOE U.S. Department of Energy Isotope Program (DOE IP), which funds the NIDC, as the …See details»
Advancell – Innovative thermo-expandable microspheres for a …
Advancell product molecules incorporate various structural characteristics based on innovative technology cultivated by Sekisui Chemical. By applying multilayer particle technology and …See details»
Technology - AdvanCell
Delivering an Unmatched Supply of Alpha Isotopes. ALPHA 212 Alpha 212 is the isotope Lead-212 or ²¹²Pb and powers AdvanCell's therapeutic pipeline. AdvanCell routinely manufactures …See details»